Intranasal Poly(Lactic-co-Glycolic Acid) Nanoparticles of Mefenamic Acid Improve Motor Expressions and Neurochemical Injury in Aluminium Chloride Originated Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of cluster science

• Publication date

  2025-04-04

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10876-025-02798-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies

  2024cited by this paper
• Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform.

  2024cited by this paper
• Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media

  2023cited by this paper
• On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles

  2022cited by this paper
• Development and in vitro Evaluation of Atazanavir Microcrystals for Intranasal Delivery

  2022cited by this paper
• Role of pro-inflammatory cytokines in Alzheimer's disease and neuroprotective effects of pegylated self-assembled nanoscaffolds

  2022cited by this paper
• Ameliorative effect of myrcene in mouse model of Alzheimer's disease.

  2021cited by this paper
• Nose to brain delivery of Rotigotine loaded solid lipid nanoparticles: Quality by design based optimization and characterization

  2021cited by this paper
• NOISE AND BRAIN.

  2020cited by this paper
• Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats

  2020cited by this paper
• Strategies to facilitate or block nose-to-brain drug delivery.

  2019cited by this paper
• Baclofen-Loaded Poly (D,L-Lactide-Co-Glycolic Acid) Nanoparticles for Neuropathic Pain Management: In Vitro and In Vivo Evaluation

  2019cited by this paper
• Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease

  2019cited by this paper
• Exploring micellar-based polymeric systems for effective nose-to-brain drug delivery as potential neurotherapeutics

  2019cited by this paper
• Nanosized nasal emulgel of resveratrol: preparation, optimization, in vitro evaluation and in vivo pharmacokinetic study

  2019cited by this paper
• Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases

  2019cited by this paper
• Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice

  2019cited by this paper
• Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.

  2019cited by this paper
• Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

  2018cited by this paper
• In situ mucoadhesive‐thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin

  2018cited by this paper
• Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.

  2017cited by this paper
• Polymeric nanoparticles based topical gel of poorly soluble drug: Formulation, ex-vivo and in vivo evaluation

  2017cited by this paper
• Update on Alzheimer's Disease Therapy and Prevention Strategies.

  2017cited by this paper
• Astaxanthin ameliorates aluminum chloride-induced spatial memory impairment and neuronal oxidative stress in mice.

  2016cited by this paper
• Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.

  2016cited by this paper
• Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.

  2015cited by this paper
• Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles

  2015cited by this paper
• PREPARATION OF CARBAMAZEPINE CHITOSAN NANOPARTICLES FOR IMPROVING NASAL ABSORPTION

  2015cited by this paper
• Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting

  2015cited by this paper
• Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy

  2015cited by this paper
• Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections

  2014cited by this paper
• An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering

  2014cited by this paper
• Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.

  2014cited by this paper
• Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting

  2014cited by this paper
• Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.

  2014cited by this paper
• Mitochondria in Cardiovascular Physiology and Disease Epoxyeicosatrienoic acids pretreatment improves amyloid-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes

  2014cited by this paper
• Development of Oral Mucoadhesive Tablets of Losartan Potassium using Natural Gum from Manilkara Zapota Seeds

  2013cited by this paper
• Inflammatory process in Alzheimer's Disease

  2013cited by this paper
• Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.

  2013cited by this paper
• Green tea extract: possible mechanism and antibacterial activity on skin pathogens.

  2012cited by this paper
• Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

  2012cited by this paper
• Role of peroxisomes in ROS/RNS-metabolism: implications for human disease.

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Effects of surfactants on the properties of PLGA nanoparticles.

  2012cited by this paper
• Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?

  2012cited by this paper
• PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Bacopa monniera selectively attenuates suppressed Superoxide dismutase activity in Diazepam induced amnesic mice

  2011cited by this paper
• In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.

  2011cited by this paper
• A review on mucoadhesive polymer used in nasal drug delivery system

  2011cited by this paper
• In vitro/in vivo Correlation of Fast Release Mephenamic Acid Microspheres in Humans

  2011cited by this paper
• Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis.

  2011cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cited by this paper
• The future of Alzheimer's disease: the next 10 years.

  2011cited by this paper
• Curcumin Exerts Neuroprotective Effects Against Homocysteine Intracerebroventricular Injection-Induced Cognitive Impairment and Oxidative Stress in Rat Brain

  2010cited by this paper
• Biodegradable polymeric nanoparticles based drug delivery systems.

  2010cited by this paper
• Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats.

  2010cited by this paper
• Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution.

  2009cited by this paper
• PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.

  2009cited by this paper
• Current advances in research and clinical applications of PLGA-based nanotechnology

  2009cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.

  2009cited by this paper
• Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery

  2009cited by this paper
• Drug delivery and nanoparticles: Applications and hazards

  2008cited by this paper
• Mefenamic Acid Shows Neuroprotective Effects and Improves Cognitive Impairment in in Vitro and in Vivo Alzheimer's Disease Models

  2006cited by this paper
• Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration

  2006cited by this paper
• The emerging nanomedicine landscape

  2006cited by this paper
• Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.

  2006cited by this paper
• Cholinesterases: roles in the brain during health and disease.

  2005cited by this paper
• Centella asiatica treatment during postnatal period enhances learning and memory in mice.

  2005cited by this paper
• Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy

  2004cited by this paper
• Memory enhancing activity of Glycyrrhiza glabra in mice.

  2004cited by this paper
• Liquid chromatography method for determination of mefenamic acid in human serum.

  2004cited by this paper
• Effect of leaves of Butea frondosa on stress, anxiety, and cognition in rats.

  2004cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.

  2003cited by this paper
• Diversity of structures and properties among catalases

  2003cited by this paper
• Ascorbic Acid: a promising memory-enhancer in mice.

  2003cited by this paper
• Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease

  2002cited by this paper
• New anti-inflammatory treatment strategy in Alzheimer's disease.

  2000cited by this paper
• Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment.

  1998cited by this paper
• Behavioral impairment in radial-arm maze learning and acetylcholine content of the hippocampus and cerebral cortex in aged mice.

  1994cited by this paper
• Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues

  1985cited by this paper
• Age-dependent deficits in spatial memory are related to impaired hippocampal kindling.

  1984cited by this paper
• Developments of a water-maze procedure for studying spatial learning in the rat.

  1984cited by this paper
• Effect of aluminum ingestion on lipid peroxidation in rats.

  1983cited by this paper
• Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.

  1978cited by this paper
• Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

  1974cited by this paper
• Animal Tissue Techniques

  1967cited by this paper
• Mechanisms of lipid peroxide formation in animal tissues.

  1966cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• BEHAVIORAL EFFECTS OF SOME PSYCHOPHARMACOLOGICAL AGENTS

  1957cited by this paper
• The measurement of the influence of drugs on voluntary activity in mice.

  1953cited by this paper

• No citing papers are available for this paper.